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1. Introduction 
Plasma unconjugated striol (E3) is now a more 
generally accepted indicator of feto-placental function 
than urinary E3-metabolite excretion [1,2]. Of the 
numerous methods which have been used to measure 
estrogens only radioreceptor assay (RRA) and especially 
radioimmune assay (RIA) easily quantitate estriol. 
Most current methods utilize ether extracts of non- 
polar plasma estrogens. Assays performed with non- 
specific antisera or steroid binding plasma protein (SBP) 
require chromatography of plasma extracts to .separate 
estriol (E3) from estradiol (E2) and estrone (Et) [2,3]. 
We have described specific azoestriol antiserum for 
direct plasma E3 assay which reliably measures E3 
even in the presence of El, E2 and E3 metabolites 
[4,5]. It had previously been th9ught hat direct 
plasma E3 assay might not accurately quantitate serum 
E3 because most plasma estriol is protein bound 
[6,10]. The present report describes quantitative 
experiments in which high affinity specific estriol 
antibody overwhelms binding of E3 by non-specific 
serum proteins, notably steroid binding globulin (SBG). 
2. Materials and methods 
Materials were obtained from the following sources: 
E3, E2 and testosterone (I") (Calbiochem. Corp.): 
tritiated estriol ([3H]E3) (spec. act. = 53 Ci/mM), 
tritiated testosterone ([3H]T) (spec. act. --- 25 Ci/mM) 
and Aquasol (New England Nuclear); DEAE Sephadex 
(Pharmacia); Biogel AI. 5 (Bio-Rad Corporation); and 
human serum albumin (Sigma). 
2.1. Pregnancy sera 
Sera obtained from 36-40 week pregnant women 
were pooled and dialysed against daily changes of 6 
liters 0.01 M sodium phosphate, 0.85% NaC1 pH 7.4 
(PBS) for 2 weeks at 4°C. Previous work has shown 
that dialysis for 48 h is sufficient o remove ndogenous 
steroids from plasma [7]. 
2.2. Antibodies (IgG) 
The antiserum used in these experiments has been 
described elsewhere [5]. IgG was prepared from serum 
obtained from a simple bleeding by (NH4)2SO4 
precipitation foUowed by DEAE Sephadex chromato- 
graphy [8]. 
2.3. Chromatography 
Sephadex G-200 (fine) and Biogel AI. 5 were defined 
with H20, equilibrated with PBS and deaerated under 
vacuum. Colunm (45 × 1.5 cm) were prepared with 
each gel and equilibrated with 500 ml PBS. The columns 
were operated at 8-20 cm pressure using a large dia- 
meter 2 liter glass reservoir to insure minimal variation 
in flow during each run. A 0.2 ml/min flow rate was 
maintained by slight changes in reservoir height as 
necessary, and 0.5 ml fractions were collected in 
graduated conical polystyrene t st tubes (Curtin 
Scientific) with the aid of a Technicon time/flow frac- 
tion collector. Aliquots (0.1 ml) were saved for radio- 
activity measurements and the rest used for optical 
density (O. D.) determinations. Calibration for mole- 
cular weight of eluent fraction utilized the elution 
profiles of Rabbit lgM and IgG, and human serum 
albumin. 
400 pg of [3H]E3 was incubated with 0.5 ml preg- 
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nancy serum (PS) for 12 h at 4°C and subsequently 
chromatographed to measure  [3H]E3 binding to serum 
proteins. For antibody competition experiments, 0.1 
ml of antiestriol IgG (10 mg/ml PBS) was mixed with 
[3H]Ea + PS, incubated as above, and chromatograph- 
ed after 0 to 60 min at room temperature. 
Antibody IgG was also incubated with [3HIE3 in 
the absence of serum and chromatographed in identical 
fashion to measure antibody binding to estriol. 
2.4. Equilibrium dialysis 
0.5 ml PS (undiluted or diluted 1/5) was placed in 
cellulose sausage casing (VWR Scientific, average pore 
diameter 24 A) and dialyzed against 3.0 ml of PBS or 
1% HSA/PBS in 5.0 ml disposable glass culture tubes 
(Curtin Scientific) sealed with parafilm. To each tube 
a given amount of tritiated steroid (350-400 pg) was 
added and the incubation was continued for 72 h at 
4°C. Varying amounts of unlabeled steroids (O-100 ng) 
were also added to the tubes in inhibition experiments. 
Duplicate resutts were averaged. No absorption of 
label occurred to glass or casing and recovery of radio- 
activity was 90-100%. 
Antibody competition for PS bound [3H]Ea was 
next studied by placing dialysis tubing containing 0.5 
rnl undiluted PS and 360 pg [aH]Ea into 2.9 ml PBS 
to which were added various dilutions of antisera 
(0.1 ml). Binding of [all]E3 to antibody was determined 
by precipitation with 50% (NH4)2SO4 [5]. 
2.5. Instrumentation 
Sample aliquots (0.1 ml) in 10 m 1 Aquasol were 
counted for aH radioactivity using a Nuclear Chicago 
Mark II Liquid Scintillation counter. O. D. was mea- 
sured with a Zeiss spectrophotometer using matched 
quartz cells. 
3. Results 
3.1. SBG affinity and capacity 
The affinity and capacity of the SBG in PS which 
potentially competes with antibody for E3 were 
determined by equilibrium dialysis. Dialysis was per- 
formed against 1% albumin/PBS and binding was 
studied by addition of from 0 to 100 ng unlabeled 
steroid to tubes containing 0.5 ml PS (diluted 1/5) and 
360 pg of the corresponding tritiated steroid in cellulose 
casing. Correction was made for binding to albumin 
and Scatchard plots constructed according to the 
method of Vermeulen and Verdan [9] (fig. 1). 
Testosterone more accurately delineates SBG 
binding parameters because of its higher affinity for 
the receptor and hence its binding data was used to 
estimate more precisely the binding capacity of SBG. 
The association constants (Ka) for SBG binding of 
E3 and T (fig.l) were KaT = 9 × 109 M -1 and KaE 3 = 
4 × 107 M -1 . KaT is in agreement with values from 
other laboratories [7,9]. However, KaE 3 as determined 
from equilibrium dialysis experiments is not entirely 
reliable. Weaker binding of E3 by SBG yields Scatchard 
plots whose intercepts on the ordinate and abscissa re 
not as accurately determined as those of testosterone. 
SBG bound 8.5 × 10 -9 M testosterone (12.5 ng 
steroid/ml PS), which is in the range reported for PS 
[9,10]. Thus there is sufficient concentration of SBG 
binding sites in PS to compete with antibody for the 
400 pg of [3H]Ea in experiments described below. 
3.2. Antibody competition for SBG bound estriol 
A typical elution profile of 0.5 ml PS inOabated 
for 12 h with 400 pg [3H]Ea is shown in fig.2. In all 
runs, 94-97% total radioactivity was recovered. As 
previously shown, SBG bound radioactivity elutes 
with the albumin fraction due to their similar mol. wt 
and physical characteristics [7,9]. Although 0.5 ml 
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Fig. 1. Scatchard plots of steroid binding to PS. Plasma (1 ml) 
diluted 1:5 was dialysed against 1% albumin (3 ml) testos- 
terone (e - e), or estriol (A - A). 
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Fig.2. Sephadex G-200 separation of 0.5 ml pregnancy serum (PS) incubated 12 hours with 400 pg 3HE3. ( ) optical 
density (OD). ( . . . . . . . . . . . .  ) Counts per minute/0.1 ml sample (CPM). 10% of total counts elutes in the mol. wt range of albumin 
while 86% is recovered unbound (see table 1). 
PS bound only 10% of [3H]E3 after chromatography, 
41.5% of [3H]E3 was bound in equilibrium dialysis 
experiments (table 1). This apparent discrepancy 
results from the more rapid disassociation during 
chromatography of that portion of serum estriol 
weakly bound to albumin, as compared to the stability 
of SBG-Ea complexes under similar conditions [7]. 
Antibody permitted to directly compete for SBG- 
bound [3H]E3 (fig.3) effectively stripped protein- 
bound estriol during a 60 min incubation (table 1). 
Similar data for 0 incubation time showed that antiboby 
did not remove all SBG-bound estriol upon mixing, 
although dimunition in 'receptor'-bound [3HIE3 was 
significant. In addition, when [3H]E3 and PS were 
incubated for 60 rnin with antibody, a portion of the 
added radioactivity (1%) was eluted earlier than either 
IgG or IgM (fig.4). 
Indirect competition ofestriol antibody with SBG for 
Table 1 
Antibody competition for protein-bound estriol 
[all]E3 bound a % 3HE3 
Binding study Antibody Serum protein free a 
Equilibrium dialysis: 
Pregnancy serum - 41.5 56 
Antibody 85 - 14 
Chromatography: 
Pregnancy serum - 10 86 
Antibody 84 - 15 
Antibody + Pregnancy 
serum 82 <1 b 14 
a Binding in chromatography studies was determined by counting pooled samples 
from graphically assigned peaks in fig. 1 and 2, and a similar figure for antibody 
binding [3H] E 3. 
bNo measurable difference from the elution profile of antibody and [3H]E3 is 
detectable in this region. 
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Fig.3. Antibody competition for serum protein-bound estriol (Sephadex G-200). 0.1 ml antiestriol lgG (1% solution) added to 
0.5 ml PS preincubated with 400 pg [3H]Es and applied to Sephadex (]-200 after 1 h. ( - - %  OD. (- . . . . .  ) = Cpm. 84% of the 
[3H]E3 added is recovered in the IgG cut. Counts 4n the albumin peak closely approximate hose observed with antibody and 
[3H]E3 alone. 
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Fig.4. Biogel AI. 5 chromatography of anti-estriol IgG mixed with preincubated [all]E3 + PS ( ) OD. ( . . . . . . . .  ) = Cpm 
antibody + [3H]E3 + PS. ( - .  - .  - )  Cpm antibody + [3H]E3. Radioactivity appears early (> 1 × 106 mol. wt) only when 
incubated with serum containing antibody and SBG-[aH] E 3. 
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Fig.5. Antibody competition for serum protein bound estriol (equilibrium dialysis). 360 pg [3H]E3 was mixed with 0.5 ml 
undiluted PS or 0.5 ml PBS and dialysed against 0.1 ml E a antiserum (above dilutions) in 2.9 ml PBS. AB binds [3HIE3 (A - A) at 
the expense of PS (o - o) and in the same amount as when dialyzed against buffer ('~ - A). Antibody preferentially strips E 3 from 
PS. 
[aH]Ea was studied by equilibrium dialysis experiments 
in which IgG was separated from PS or PBS by a 
semipermiable membrane (fig.5). Various dilutions of 
antiserum bound identical [aH]Ea whether dialysed 
against PS or PBS. PS however bound 40% of label in 
the absence of antibody but bound successively ess 
[a H]Es in competition with increasing antibody con- 
centration. High affinity azoestriol IgG thus preferen- 
tially bound estriol at the expense of albumin and 
SBG. 
4. Discussion 
Human serum contains everal glycoproteins of mol. 
wt 52 000 [7,10] which bind small mol. wt non-poly- 
peptide hormones with moderate affinity [11,12]. The 
increase of such 'receptor' proteins in certain hyper- 
estrogenic states e.g. pregnancy [13] suggests their 
importance as hormone buffers for regulation of 
'active' (unbound) hormone levels [ 14]. Albumin also 
binds these hormones but with demonstrably ess 
affinity. These serum 'receptors' are relatively non- 
specific, binding molecules which vary widely in 
structure and biological activity. Corticosterone-binding 
globulin (CBG) binds cortisol, corticosterone and 
progesterone [15]. Thyroxine-binding globulin has 
strong affinity with several organic dyes in addition to 
thyroxine and triiodothyronine [ 18]. Likewise, in 
contradistinction to fixed tissue receptors, SBG reacts 
with several different steroids possessing 17/~ hydroxyl 
groups and coplanar A and B rings [17]. Other func- 
tional groups, which serve as determinants of the 
immune response to steroids [18] are of vastly, less 
importance as evidenced by the relatively high associa- 
tion of SBG for both testosterone and 17/3-estradiol 
[ 19]. The semispecific nature of serum binding pro- 
teins contrasts markedly with the exquisite specificity 
of the immune response [18]. 
Potentially an interesting way to dissociate striol- 
SBG might be the addition of testosterone to assay 
solutions ince the two steroids are bound competitively 
by SBG and the K a is much higher for the latter, in 
marked contrast o E3-specific antibody [8]. 8-Anilino 
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sulphonic acid serves an analogous role in displacing 
protein-bound thyroxine for serum RIA [20]. Similar 
considerations would influence crucial experiments 
with biologically active estradiol (E2) since more 
avidly bound testosterone also displaces E2 from their 
shared serum 'receptor', SBG. Such experiments have 
been performed (JDG, unpublished, and [21] ). It 
would seem reasonable that substrate functional 
groups concerned with SBG binding do not include 
all haptenic determinants required for antibody recog- 
nition. 
The observation of high mol. wt complexes (rigA) 
is in harmony with earlier observations (SJG, unpublish- 
ed) of rapidly formed precipitin bands when pregnancy 
urine samples are layed on appropriate estriol/estradiol 
antisera. Whether these complexes represent binding of 
estriol antibody to SBG-E3 is not determined. Ultra- 
centrifuge studies utilizing purified SBG~ ED, and 
specific antiestradiol antibody are now in progress. 
The current work demonstrates that a specific, 
high affinity antibody competes effectively with less 
specific, lower affinity serum protein(s) for binding 
of E 3 substrate. SBG and other serum binding pro- 
teins rapidly disassociate from E3 during gel chromato- 
graphy (table 1) thus giving further evidence to the 
buffering nature of serum binding proteins. Anti- 
bodies [22] and tissue receptors [23] however, 
characteristically have low back molecular ate con- 
stants, thus accounting for their high K a values for 
ligands. Therefore specific anti-estriol IgG maintains 
[3H]E3 binding against he concentration gradient 
effected by chromatography (table 1). Equilibrium 
dialysis and chromatography experiments show that 
high affinity estriol antibody efficiently strips PS 
proteins of E3. If serum binding proteins exist for 
solubility and transport of these relatively insoluble 
hormones, it would therefore seem reasonable that the 
latter be released to antibody or tissue receptor pos- 
sessing higher inherent affinity. 
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